Related Experiment Video
Updated: Aug 18, 2026

Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring
Published on: December 9, 2010
[Superparamagnetic iron particles. The clinical results in the MR diagnosis of liver metastases]
1Abteilung für Röntgendiagnostik und Nuklearmedizin, Klinikum Steglitz, Freie Universität Berlin.
Abstract:
The diagnostic value of superparamagnetic iron particles as a tissue-specific MR contrast medium of the reticulo-endothelial system was studied in 30 patients. All patients had liver metastases (maximally 5 known metastases on MR). The patients were examined on a 1.5 Tesla scanner before and after a slow intravenous injection of iron particles (AMI-25) at a dose of 15 mumol/kg. Contrast injection led to a significant reduction of signal strength in the liver parenchyma (p < or = 0.001) but not in the metastases. Contrast enhanced spin echo sequences (SE 2300/45) provided the most marked liver/tumour contrast, greater than the contrast values of T1- and T2-weighted images (p < or = 0.01). After the intravenous injection of iron particles, small metastases in particular are more easily demonstrated. A new, rapid T2-weighted pulse sequence (PSIF 10/15/15 degrees) results in the elimination of vascular signals and leads to better differentiation between lesions and intrahepatic vessels. The use of superparamagnetic iron particles as an MR contrast medium improves the demonstration of liver metastases.
Insights
Superparamagnetic iron particles enhance MRI detection of liver metastases. This contrast agent significantly improves liver/tumor contrast, aiding in the visualization of small metastatic lesions.
Area of Science:
- Radiology
- Medical Imaging
- Oncology
Background:
- Superparamagnetic iron particles (SPIOs) are investigated as MRI contrast agents.
- The reticulo-endothelial system (RES) plays a role in SPIO distribution.
- Accurate detection of liver metastases is crucial for patient management.
Purpose of the Study:
- To evaluate the diagnostic value of SPIOs (AMI-25) as a liver-specific MR contrast medium.
- To assess the effectiveness of SPIOs in improving the detection of liver metastases.
- To compare different MRI sequences for optimal contrast enhancement.
Main Methods:
- 30 patients with known liver metastases underwent MRI on a 1.5 Tesla scanner.
- Examinations were performed before and after intravenous injection of AMI-25 (15 mumol/kg).
- Standard and novel T2-weighted sequences (SE 2300/45, PSIF 10/15/15 degrees) were utilized.
Main Results:
- SPIO injection significantly reduced liver parenchyma signal (p < 0.001) but not metastases.
- Contrast-enhanced spin echo sequences (SE 2300/45) yielded superior liver/tumor contrast (p < 0.01).
- A rapid T2-weighted sequence (PSIF) improved lesion differentiation from intrahepatic vessels.
Conclusions:
- Superparamagnetic iron particles effectively serve as an MR contrast medium for the RES.
- SPIOs significantly improve the demonstration and detection of liver metastases, especially smaller ones.
- Optimized MRI sequences enhance the diagnostic utility of SPIOs in liver cancer imaging.
More Related Videos
Related Concept Videos
Magnetic Resonance Imaging
Imaging Studies IV: Magnetic Resonance Imaging

